Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

How can we further optimize the management of RCC patients

Date

02 Dec 2022

Session

Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Topics

Tumour Site

Hepatobiliary Cancers

Presenters

Marniza Binti Saad

Authors

M. Binti Saad

Author affiliations

  • Department Of Clinical Oncology, UMMC - University Malaya Medical Centre, 59100 - Kuala Lumpur/MY

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.